Watchlist Price Alert

Defiance Nasdaq Junior Bi... (IBBJ)

NASDAQ: IBBJ · Real-Time Price · USD

29.87

-0.02 (-0.07%)

At close: Dec 02, 2021, 9:00 PM

-0.07% (1D)

Bid	-
Market Cap	8.23M
AUM	8.24M
NAV	29.93
EPS (ttm)	0.00
PE Ratio (ttm)	n/a
Shares Out	275.38K
Inception Date	Aug 3, 2020

Ask	-
Volume	2.2K
Open	29.87
Previous Close	29.89
Day's Range	29.86 - 29.90
52-Week Range	27.85 - 41.45
Holdings	3
Expense Ratio	0.45%

About IBBJ

The investment seeks to track the total return performance, before fees and expenses, of the NASDAQ Junior Biotechnology Index. The index is a rules-based index that consists of a portfolio of the stock of U.S.-listed small capitalization ("junior") companies screened from the universe of the NASDAQ Biotechnology Index. The fund will generally use a "replication" strategy to achieve its investment objective, meaning it will generally invest in all of the component securities of the index in the same approximate proportions as in the index. The fund is non-diversified.

Asset Class Equity

Ticker Symbol IBBJ

Inception Date Aug 3, 2020

Provider Defiance

Website Fund Home Page

Exchange NASDAQ

Top Sectors

Sector	Weight %
Healthcare	100.00%

All Sectors

Top 10 Holdings 100.00% of assets

Name	Symbol	Weight
Cash & Other	Cash&Other	99.91%
Pdl Biopharma Inc	PDLI	0.09%

View More Holdings

Dividends Dividend Yield 0.87%

Ex-Dividend	Amount	Payment Date
Dec 29, 2020	$0.3000	Dec 31, 2020

Full Dividend History

News

3 years ago · etf.com

ETF Odds & Ends: Closures Accelerate

Plus, a large number of name and index changes occurred during the past two weeks.

3 years ago · etf.com

ETF Odds & Ends: Launches Resurge

Plus, expense ratio changes and other ETF developments occurred during the week.

3 years ago · etftrends.com

Biotech ETFs Benefit From Moderna Dual Booster Shot News

As the stock market attempts to reverse the recent pullback this month, Moderna shares climbed higher on Thursday after the company announced that it's creating a dual-purpose vaccine booster shot tha...

3 years ago · zacks.com

Healthcare ETFs Surge on FDA Full-Vaccine Nod & Deal News

The FDA granted full approval of a COVID-19 vaccine made by Pfizer (PFE) and BioNTech that could accelerate inoculations in the United States.

3 years ago · etftrends.com

Bet on Biotech Small Caps to Bounce Back

Large cap biotechnology have strengthened in recent months, but smaller counterparts are still waiting on their 2021 moment. When that happens, the Defiance Nasdaq Junior Biotechnology ETF (IBBJ) coul...

3 years ago · investorplace.com

7 Stocks to Buy Now if You're Feeling Greedy While Others Are Fearful

Stock markets run on fear and greed in the short term. Here are seven stocks to buy that look like they have significant long-term upside.

4 years ago · seekingalpha.com

Biotech Innovations Remain At Forefront

The first quarter of 2021 was challenging for the biotechnology industry, as the selloff in March represented a sharp reversal from record highs in February. While the sector has remained relatively r...

4 years ago · seekingalpha.com

Moving Beyond COVID In Biopharma

Just over one year after COVID-19 disrupted our lives, we are now getting to the point where multiple vaccine options are nearly ubiquitous for those in the United States. Per the CDC, as of April 12,...